The FDA has granted fast-track approval to the drug telisotuzumab vedotin (sold as Emrelis) as a first-of-its-kind treatment for certain people who have non-squamous non-small-cell lung cancer.

With Mother’s Day approaching, we asked five top doctors for maternal health tips that showed just how smart their moms ...

Every time you visit the grocery store, your brain is absorbing countless food-packaging cues. Those cues influence your choices more than you think.

April 21, 2025 – The FDA just approved the popular drug Dupixent for adults and kids 12 and up with chronic spontaneous urticaria (CSU), a long-lasting itchy skin condition, when regular ...

Ankle injuries are often thought of as sports injuries. But you don't have to be an athlete or even a "weekend warrior" to turn your ankle and hurt it. Something as simple as walking on an uneven ...

Astaxanthin is the pigment that gives salmon and lobster a reddish color. It's a carotenoid. That's a chemical naturally found in some plants and animals. Pink seafood, such as salmon, shrimp, and ...

Finding out that cancer has spread is never welcome news, but don't assume it's the worst news. The 5-year survival rate for prostate cancer that has moved into nearby parts of the body is nearly ...

It's normal for your canine companion to shed hair-- sometimes lots of it. What isn't routine is for that shedding to result in noticeable bald spots on your dog. Why do dogs sometimes lose too ...

Chronic inflammatory demyelinating polyneuropathy (CIDP) is a long-term neurological disorder that targets your body’s nerves. Anyone can get CIDP, but it’s most common in older adults and ...

Each year, there are more than 401,500 cases of pet poisoning in the U.S. Many of these were caused by household substances that may seem perfectly harmless to you. But just because something is ...

Rawhide chews are a popular treat for dogs. You might have heard that rawhide is good for your dog’s teeth and helps with their natural instinct to chew. But are there any drawbacks to giving ...